EPIX News and Press, ESSA Pharma Inc. From 08/08/23

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2023 Canada NewsWire Completion of the Phase 1 EPI-7386 combination study with Xtandi ® (enzalutamide) expected in the third calendar quarter of 202...

ESSA Pharma Appoints Lauren Merendino to its Board of Directors PR Newswire SOUTH SAN FRANCISCO , California and VANCOUVER, Canada , June 6, 2023 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceuti...

ESSA Pharma to Present at 2023 Jefferies Healthcare Conference Canada NewsWire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , June 1, 2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company foc...

ESSA Pharma to Present at JMP Securities Life Sciences Conference Canada NewsWire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , May 11, 2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company ...

2023-05-09 08:48:50 ET ESSA Pharma press release ( NASDAQ: EPIX ): Q2 GAAP EPS of -$0.16 beats by $0.04 . ESSA recorded a comprehensive loss of $7.1 million for the first quarter ended March 31, 2023, At March 31, 2023, the Company had available cash reserves and s...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2023 PR Newswire Entered into clinical trial support agreement with Janssen to supply Erleada ® (apalutamide) and Zytiga ® (abiraterone acetate) for ...

ESSA Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference ESSA Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , April 18,...

ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer Canada NewsWire SOUTH SAN FRANCISCO, Calif. , and VANCOUVER, Canada , April 12, 2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or th...

ESSA Pharma to Present at the Oppenheimer 33rd Annual Healthcare Conference Canada NewsWire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , March 8, 2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmac...

ESSA Pharma Announces Presentations at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) Canada NewsWire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , Feb. 13, 2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company"...